Literature DB >> 31172941

CCL2 mobilizes ALIX to facilitate Gag-p6 mediated HIV-1 virion release.

David O Ajasin1, Vasudev R Rao1, Xuhong Wu2, Santhamani Ramasamy1, Mario Pujato3, Arthur P Ruiz1, Andras Fiser4, Anne R Bresnick3, Ganjam V Kalpana2, Vinayaka R Prasad1.   

Abstract

Cellular ESCRT machinery plays pivotal role in HIV-1 budding and release. Extracellular stimuli that modulate HIV-1 egress are currently unknown. We found that CCL2 induced by HIV-1 clade B (HIV-1B) infection of macrophages enhanced virus production, while CCL2 immuno-depletion reversed this effect. Additionally, HIV-1 clade C (HIV-1C) was refractory to CCL2 levels. We show that CCL2-mediated increase in virus production requires Gag late motif LYPX present in HIV-1B, but absent in HIV-1C, and ALIX protein that recruits ESCRT III complex. CCL2 immuno-depletion sequestered ALIX to F-actin structures, while CCL2 addition mobilized it to cytoplasm facilitating Gag-ALIX binding. The LYPX motif improves virus replication and its absence renders the virus less fit. Interestingly, novel variants of HIV-1C with PYRE/PYKE tetrapeptide insertions in Gag-p6 conferred ALIX binding, CCL2-responsiveness and enhanced virus replication. These results, for the first time, indicate that CCL2 mediates ALIX mobilization from F-actin and enhances HIV-1 release and fitness.

Entities:  

Keywords:  ALIX; CCL2; Gag p6; HIV-1; HIV-1 clade C; human; infectious disease; late domain; microbiology; virus

Mesh:

Substances:

Year:  2019        PMID: 31172941      PMCID: PMC6592687          DOI: 10.7554/eLife.35546

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  68 in total

1.  AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding.

Authors:  Bettina Strack; Arianna Calistri; Stewart Craig; Elena Popova; Heinrich G Göttlinger
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

2.  Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences.

Authors:  Weizhong Li; Adam Godzik
Journal:  Bioinformatics       Date:  2006-05-26       Impact factor: 6.937

3.  Structural basis for viral late-domain binding to Alix.

Authors:  Sangho Lee; Anjali Joshi; Kunio Nagashima; Eric O Freed; James H Hurley
Journal:  Nat Struct Mol Biol       Date:  2007-02-04       Impact factor: 15.369

4.  Chemokines induce migration and changes in actin polymerization in adult rat brain microglia and a human fetal microglial cell line in vitro.

Authors:  A K Cross; M N Woodroofe
Journal:  J Neurosci Res       Date:  1999-01-01       Impact factor: 4.164

5.  Natural deletion of L35Y36 in p6 gag eliminate LYPXnL/ALIX auxiliary virus release pathway in HIV-1 subtype C.

Authors:  Ajit Patil; Jayanta Bhattacharya
Journal:  Virus Res       Date:  2012-09-04       Impact factor: 3.303

6.  HIV-1 clade B and C isolates exhibit differential replication: relevance to macrophage-mediated neurotoxicity.

Authors:  Agnes A Constantino; Yunlong Huang; Hong Zhang; Charles Wood; Jialin C Zheng
Journal:  Neurotox Res       Date:  2011-02-19       Impact factor: 3.911

Review 7.  Virus budding and the ESCRT pathway.

Authors:  Jörg Votteler; Wesley I Sundquist
Journal:  Cell Host Microbe       Date:  2013-09-11       Impact factor: 21.023

8.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.

Authors:  Fabian Sievers; Andreas Wilm; David Dineen; Toby J Gibson; Kevin Karplus; Weizhong Li; Rodrigo Lopez; Hamish McWilliam; Michael Remmert; Johannes Söding; Julie D Thompson; Desmond G Higgins
Journal:  Mol Syst Biol       Date:  2011-10-11       Impact factor: 11.429

9.  The architecture of actin filaments and the ultrastructural location of actin-binding protein in the periphery of lung macrophages.

Authors:  J H Hartwig; P Shevlin
Journal:  J Cell Biol       Date:  1986-09       Impact factor: 10.539

Review 10.  Is HIV-1 evolving to a less virulent form in humans?

Authors:  Kevin K Ariën; Guido Vanham; Eric J Arts
Journal:  Nat Rev Microbiol       Date:  2007-01-04       Impact factor: 60.633

View more
  4 in total

1.  Cytotoxic Lymphocytes Target HIV-1 Gag Through Granzyme M-Mediated Cleavage.

Authors:  Elisa Saccon; Flora Mikaeloff; Pol Figueras Ivern; Ákos Végvári; Anders Sönnerborg; Ujjwal Neogi; Robert van Domselaar
Journal:  Front Immunol       Date:  2021-04-19       Impact factor: 7.561

2.  Small Animal Model of Post-chemotherapy Tuberculosis Relapse in the Setting of HIV Co-infection.

Authors:  Matthew B Huante; Tais B Saito; Rebecca J Nusbaum; Kubra F Naqvi; Sadhana Chauhan; Robert L Hunter; Jeffrey K Actor; Jai S Rudra; Mark A Endsley; Joshua G Lisinicchia; Benjamin B Gelman; Janice J Endsley
Journal:  Front Cell Infect Microbiol       Date:  2020-04-16       Impact factor: 5.293

3.  The Signature Amino Acid Residue Serine 31 of HIV-1C Tat Potentiates an Activated Phenotype in Endothelial Cells.

Authors:  Malini Menon; Roli Budhwar; Rohit Nandan Shukla; Kiran Bankar; Madavan Vasudevan; Udaykumar Ranga
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

Review 4.  The Interplay between ESCRT and Viral Factors in the Enveloped Virus Life Cycle.

Authors:  Bo Meng; Andrew M L Lever
Journal:  Viruses       Date:  2021-02-20       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.